FDA Should Propose Rule on Federal Preemption of Failure-to-Warn Lawsuits

photo-1About the Author James D. Miller, Esq. has been a partner at the Wasthinton, D.C. office of King Spalding , L.L.P. since 1983. His practice is primarily trials, appeals, and arbitrations. He has represented a many companies across the country in litigation involving pharmaceuticals, punitive damages claims, and asbestos. This article was originally published by the Washington Legal Foundation (WLF) as part of their educational "Legal Backgrounder" series of papers. WLF is a national, non-profit public interest law and policy center which litigates, publishes, and communicates to advance the cause of freedom and free enterprise. Reprinted with permission.